Analyst Research Report Snapshot

Title:

UPDATE: Lupin Receives FDA Approval for Generic Plan B Tablets, 0.75 mg Tablets

Price:

$5.00

Provider:

News Bites Pty Limited

Date:

25 Jan 2013

Pages:

16

Type:

AcrobatPDF

Companies referenced:

LUPN.NS

Available for Immediate Download
Summary:

Lupin Limited (LUPIN), India's 4th largest pharmaceuticals company by market capitalisation, traded between an intraday low of Rs587.0 and a high of Rs601.75. The price range has expanded in the last two days (from Rs7.10 two days ago to Rs14.75 today) which, accompanied by a price rise, is a bul...

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.